CVC private equity completely takes over Stella
Thursday, 2 July 2009
Source: http://www.etravelblackboard.com/showarticle.asp?id=94200&nav=98
After acquiring a majority share of Stella group from MFS Limited early last year, CVC Asia Pacific has performed a fait accompli and snapped up all remaining shares left in a bold move yesterday.
Administrators of the collapsed Octaviar today announced the sell-off of the remaining 35% of Stella Group to CVC Capital Partners who, through Global Voyager Holdings, already own 65% of Stella Group.
Additionally, the administrators from Deloitte add, “As part of the consideration for the sale of the shares and loan note, GVH [Global Voyager Holdings] and related parties have agreed to release a claim brought in the Supreme Court of New South Wales against OSH [Octaviar Stella Holdings] and OCV [Octaviar] by GVH’s subsidiary Global Voyager Pty Limited.”
Earlier in the year, Deloitte had issued a memo that Octaviar was making provisions for a $249 million warranty claim for CVC, after it was understood that the private equity company demanded compensation for being sold a dud and would be taking the matter to court.
CVC is understood to have been upset at the $17.2 million before tax earnings result, which was well below the $210 million Stella had forecasted.
By making the disappearance of the court case part and parcel of the sell-off, Octaviar now had one less problem to take care of.
CVC had initially bought the 65% stake in Stella Group for $400 million, and also shouldered $900 million in Stella debts.
It is currently unknown how much the remaining 35% stake was sold for, only that it too was a “Share and Loan Note Sale Agreement”.
- Forums
- ASX - By Stock
- cvc completely takes over stella
OCV
octaviar limited
CVC private equity completely takes over StellaThursday, 2 July...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online